The estimated Net Worth of Jeffrey Thomas Perez is at least $2.2 Миллион dollars as of 9 August 2024. Mr. Perez owns over 58,823 units of Precigen Inc stock worth over $720,804 and over the last 10 years he sold PGEN stock worth over $0. In addition, he makes $1,480,500 as Senior Vice President - Intellectual Property Affairs at Precigen Inc.
Jeffrey has made over 29 trades of the Precigen Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 58,823 units of PGEN stock worth $50,000 on 9 August 2024.
The largest trade he's ever made was exercising 175,000 units of Precigen Inc stock on 15 May 2020 worth over $169,750. On average, Jeffrey trades about 15,643 units every 54 days since 2014. As of 9 August 2024 he still owns at least 743,097 units of Precigen Inc stock.
You can see the complete history of Mr. Perez stock trades at the bottom of the page.
Jeffrey T. Perez J.D. serves as Senior Vice President - Intellectual Property Affairs of the Company. Mr. Perez has served as our Senior Vice President, Intellectual Property Affairs since August 2014. Mr. Perez is currently a member of the board of directors of AquaBounty Technologies Inc., a public biotechnology company (Nasdaq: AQB) that was our majority-owned subsidiary until October 2019. Before joining Precigen, Mr. Perez was Managing Director and Associate General Counsel and Intellectual Property at Third Security, LLC, where he evaluated potential investments of Third Security’s managed investment funds. Additionally, Mr. Perez worked with Third Security portfolio companies in evaluating and developing their intellectual property strategies and general corporate activities. Prior to joining Third Security, Mr. Perez practiced intellectual property law with the law firm of Hunton & Williams LLP in Washington D.C. Mr. Perez’s previous work involved client consultation, litigation, agreement work, opinion drafting, and patent procurement. Mr. Perez received a B.S. from Cornell University and his J.D. from George Mason University School of Law.
As the Senior Vice President - Intellectual Property Affairs of Precigen Inc, the total compensation of Jeffrey Perez at Precigen Inc is $1,480,500. There are 4 executives at Precigen Inc getting paid more, with Randal Kirk having the highest compensation of $2,067,620.
Jeffrey Perez is 48, he's been the Senior Vice President - Intellectual Property Affairs of Precigen Inc since 2014. There are 16 older and 2 younger executives at Precigen Inc. The oldest executive at Precigen Inc is Robert Shapiro, 81, who is the Lead Independent Director.
Over the last 5 years, insiders at Precigen Inc have traded over $44,216,787 worth of Precigen Inc stock and bought 52,689,457 units worth $114,197,137 . The most active insiders traders include Randal J Kirk, Trading S.A. Ares и Helen Sabzevari. On average, Precigen Inc executives and independent directors trade stock every 9 days with the average trade being worth of $358,866. The most recent stock trade was executed by Randal J Kirk on 9 August 2024, trading 23,529,411 units of PGEN stock currently worth $19,999,999.
precigen, inc. discovers and develops the next generation of gene and cellular therapies in the united states. it also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. in addition, the company offers ultravector platform that incorporates advanced dna construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbil15, a gene that enhances functional characteristics of immune cells; sleeping beauty, a non-viral transposon/transposase system; attsite recombinases, which breaks and rejoins dna at specific sequences; adenoverse technology platform, a library of engineered adenovector serotypes; and l. lactis is a food-grade bacterium. additionally, it provides rheoswitch inducible gene switch that provides qua
Precigen Inc executives and other stock owners filed with the SEC include: